GPCRs of adrenal chromaffin cells & catecholamines: The plot thickens

International Journal of Biochemistry and Cell Biology

Volumn 77, Issue , 2016, Pages 213-219

  Lymperopoulos, Anastasios ^a   Brill, Ava ^a   McCrink, Katie A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Catecholamine secretion; Chromaffin cell; GPCR; GRK2; Signal transduction; Arrestin

Indexed keywords

ADRENERGIC RECEPTOR; ADRENOMEDULLIN RECEPTOR; BETA ARRESTIN; CATECHOLAMINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR;

ARTICLE; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CHROMAFFIN CELL; HUMAN; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ADRENAL GLAND; ANIMAL; CYTOLOGY; METABOLISM;

ADRENAL GLANDS; ANIMALS; CATECHOLAMINES; CHROMAFFIN CELLS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84959048896     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2016.02.003     Document Type: Article

References (86)

1. Albillos, A., Gandia, L., Michelena, P., Gilabert, J.A., del Valle, M., Carbone, E., Garcia, A.G., The mechanism of calcium channel facilitation in bovine chromaffin cells. J. Physiol. 494 (1996), 687–695.
2. Armando, I., Jezova, M., Bregonzio, C., Baiardi, G., Saavedra, J.M., Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann. N.Y. Acad. Sci. 1018 (2004), 302–309.
3. Bathgate-Siryk, A., Dabul, S., Pandya, K., Walklett, K., Rengo, G., Cannavo, A., De Lucia, C., Liccardo, D., Gao, E., Leosco, D., Koch, W.J., Lymperopoulos, A., Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension 63 (2014), 404–412.
4. Bauer, C.S., Woolley, R.J., Teschemacher, A.G., Seward, E.P., Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13-1. J. Neurosci. 27 (2007), 212–219.
5. Berkowitz, D.E., Price, D.T., Bello, E.A., Page, S.O., Schwinn, D.A., Localization of messenger RNA for three distinct alpha 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology 81 (1994), 1235–1244.
6. Blackmer, T., Larsen, E.C., Bartleson, C., Kowalchyk, J.A., Yoon, E.J., Preininger, A.M., Alford, S., Hamm, H.E., Martin, T.F., G protein betagamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis. Nat. Neurosci. 8 (2005), 421–425.
7. Breault, L., Yon, L., Montero, M., Chouinard, L., Contesse, V., Delarue, C., Fournier, A., Lehoux, J.G., Vaudry, H., Gallo-Payet, N., Occurrence and effect of PACAP in the human fetal adrenal gland. Ann. N.Y. Acad. Sci. 921 (2000), 429–433.
8. Brede, M., Nagy, G., Philipp, M., Sorensen, J.B., Lohse, M.J., Hein, L., Differential control of adrenal and sympathetic catecholamine release by α-adrenoceptor subtypes. Mol. Endocrinol. 17 (2003), 1640–1646.
9. Capote, L.A., Mendez Perez, R., Lymperopoulos, A., GPCR signaling and cardiac function. Eur. J. Pharmacol. 763 (2015), 143–148.
10. Carabelli, V., Giancippoli, A., Baldelli, P., Carbone, E., Artalejo, A.R., Distinct potentiation of L-type currents and secretion by cAMP in rat chromaffin cells. Biophys. J. 85 (2003), 1326–1337.
11. Cavadas, C., Cefai, D., Rosmaninho-Salgado, J., Vieira-Coelho, M.A., Moura, E., Busso, N., Pedrazzini, T., Grand, D., Rotman, S., Waeber, B., Aubert, J.F., Grouzmann, E., Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 10497–10502.
12. Chen, X.K., Wang, L.C., Zhou, Y., Cai, Q., Prakriya, M., Duan, K.L., Sheng, Z.H., Lingle, C., Zhou, Z., Activation of GPCRs modulates quantal size in chromaffin cells through G(betagamma) and PKC. Nat. Neurosci. 8 (2005), 1160–1168.
13. Cortez, V., Santana, M., Marques, A.P., Mota, A., Rosmaninho-Salgado, J., Cavadas, C., Regulation of catecholamine release in human adrenal chromaffin cells by β-adrenoceptors. Neurochem. Int. 60 (2012), 387–393.
14. 2+ channels and adrenal catecholamine release by G protein coupled receptors. Cell. Mol. Neurobiol. 30 (2010), 1201–1208.
15. De Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W., Unger, T., International union of pharmacology, XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000), 415–472.
16. de Quidt, M.E., Emson, P.C., Neuropeptide Y in the adrenal gland: characterization, distribution and drug effects. Neuroscience 19 (1986), 1011–1022.
17. Eaton, M.J., Duplan, H., Useful cell lines derived from the adrenal medulla. Mol. Cell. Endocrinol. 228 (2004), 39–52.
18. Ghzili, H., Grumolato, L., Thouennon, E., Tanguy, Y., Turquier, V., Vaudry, H., Anouar, Y., Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front. Neuroendocrinol. 29 (2008), 128–141.
19. Grumolato, L., Louiset, E., Alexandre, D., Ait-Ali, D., Turquier, V., Fournier, A., Fasolo, A., Vaudry, H., Anouar, Y., PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur. J. Neurosci. 17 (2003), 71–82.
20. Hamelink, C., Tjurmina, O., Damadzic, R., Young, W.S., Weihe, E., Lee, H.W., Eiden, L.E., Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 461–466.
21. Hansel, D.E., Eipper, B.A., Ronnett, G.V., Neuropeptide Y functions as a neuroproliferative factor. Nature 410 (2001), 940–944.
22. Harkins, A.B., Fox, A.P., Activation of purinergic receptors by ATP inhibits secretion in bovine adrenal chromaffin cells. Brain Res. 885 (2000), 231–239.
23. Harmar, A.J., Sheward, W.J., Morrison, C.F., Waser, B., Gugger, M., Reubi, J.C., Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology 145 (2004), 1203–1210.
24. Hervonen, A., Kanerva, L., Neuronal differentiation in human fetal adrenal medulla. Int. J. Neurosci. 5 (1973), 43–46.
25. Hong, M., Li, S., Fournier, A., St-Pierre, S., Pelletier, G., Role of neuropeptide Y in the regulation of tyrosine hydroxylase gene expression in rat adrenal glands. Neuroendocrinology 61 (1995), 85–88.
26. Isobe, K., Kaneko, M., Kaneko, S., Nissato, S., Nanmoku, T., Takekoshi, K., Okuda, Y., Kawakami, Y., Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis. Regul. Pept. 123 (2004), 29–32.
27. Jafferjee, M., Reyes Valero, T., Marrero, C., McCrink, K.A., Brill, A., Lymperopoulos, A., GRK2 upregulation creates a positive feedback loop for catecholamine production in chromaffin cells. Mol. Endocrinol., #30, 2016, 10.1210/me.2015-1305 (in press).
28. Jarvis, S.E., Barr, W., Feng, Z.P., Hamid, J., Zamponi, G.W., Molecular determinants of syntaxin 1 modulation of N-type calcium channels. J. Biol. Chem. 277 (2002), 44399–44407.
29. Karkoulias, G., Mastrogianni, O., Ilias, I., Lymperopoulos, A., Taraviras, S., Tsopanoglou, N., Sitaras, N., Flordellis, C.S., Alpha 2-adrenergic receptors decrease DNA replication and cell proliferation and induce neurite outgrowth in transfected rat pheochromocytoma cells. Ann. N.Y. Acad. Sci. 1088 (2006), 335–345.
30. Karkoulias, G., Mastrogianni, O., Lymperopoulos, A., Paris, H., Flordellis, C., Alpha(2)-Adrenergic receptors activate MAPK and Akt through a pathway involving arachidonic acid metabolism by cytochrome P450-dependent epoxygenase, matrix metalloproteinase activation and subtype-specific transactivation of EGFR. Cell. Signal. 18 (2006), 729–739.
31. Kobayashi, H., Yamamoto, R., Kitamura, K., Kuwasako, K., Minami, S., Yanagita, T., Shiraishi, S., Yokoo, H., Eto, T., Wada, A., Selective inhibition of nicotinic cholinergic receptors by proadrenomedullin N-terminal 12 peptide in bovine adrenal chromaffin cells. Brain Res. Mol. Brain Res. 87 (2001), 175–183.
32. Kobayashi, H., Yanagita, T., Yokoo, H., Wada, A., Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells. Peptides 22 (2001), 1895–1901.
33. Kobayashi, H., Yanagita, T., Yokoo, H., Wada, A., Pathophysiological function of adrenomedullin and proadrenomedullin N-terminal peptides in adrenal chromaffin cells. Hypertens. Res. 26 (2003), S71–S78.
34. Korner, M., Waser, B., Reubi, J.C., High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia. Clin. Cancer Res. 10 (2004), 8426–8433.
35. Lamouche, S., Yamaguchi, N., PACAP release from the canine adrenal gland in vivo: its functional role in severe hypotension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003), R588–R597.
36. Link, R.E., Desai, K., Hein, L., Stevens, M.E., Chruscinski, A., Bernstein, D., Barsh, G.S., Kobilka, B.K., Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273 (1996), 803–805.
37. Luke, T.M., Hexum, T.D., Tyrosine hydroxylase phosphorylation increases in response to ATP and neuropeptide Y co-stimulation of ERK2 phosphorylation. Pharmacol. Res. 58 (2008), 52–57.
38. Lymperopoulos, A., Bathgate, A., Arrestins in the cardiovascular system. Prog. Mol. Biol. Transl. Sci. 118 (2013), 297–334.
39. Lymperopoulos, A., Bathgate, A., Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown. Pharmacogenomics 13 (2012), 323–341.
40. Lymperopoulos, A., Karkoulias, G., Koch, W.J., Flordellis, C.S., Alpha2-adrenergic receptor subtype-specific activation of NF-kappaB in PC12 cells. Neurosci. Lett. 402 (2006), 210–215.
41. Lymperopoulos, A., Negussie, S., βArrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or “good cop, bad cop”?. Int. J. Mol. Sci. 14 (2013), 24726–24741.
42. Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Koch, W.J., Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. J. Am. Coll. Cardiol. 57 (2011), 356–365.
43. Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Soltys, S., Koch, W.J., An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 5825–5830.
44. Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A.D., Koch, W.J., Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat. Med. 13 (2007), 315–323.
45. Lymperopoulos, A., Rengo, G., Gao, E., Ebert, S.N., Dorn, G.W. II, Koch, W.J., Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J. Biol. Chem. 285 (2010), 16378–16386.
46. Lymperopoulos, A., Rengo, G., Koch, W.J., Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. Trends Mol. Med. 13 (2007), 503–511.
47. Lymperopoulos, A., Rengo, G., Koch, W.J., GRK2 inhibition in heart failure: something old, something new. Curr. Pharm. Des. 18 (2012), 186–191.
48. Lymperopoulos, A., Rengo, G., Koch, W.J., Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ. Res. 113 (2013), 739–753.
49. Lymperopoulos, A., Rengo, G., Zincarelli, C., Soltys, S., Koch, W.J., Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity. Mol. Ther. 16 (2008), 302–307.
50. Lymperopoulos, A., Sturchler, E., Bathgate-Siryk, A., Dabul, S., Garcia, D., Walklett, K., Rengo, G., McDonald, P., Koch, W.J., Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism. J. Am. Coll. Cardiol. 64 (2014), 2805–2806.
51. Masada, K., Nagayama, T., Hosokawa, A., Yoshida, M., Suzuki-Kusaba, M., Hisa, H., Kimura, T., Satoh, S., Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs. Am. J. Physiol. 276 (1999), R1118–R1124.
52. Mazzocchi, G., Albertin, G., Andreis, P.G., Neri, G., Malendowicz, L.K., Champion, H.C., Bahcelioglu, M., Kadowitz, P.J., Nussdorfer, G.G., Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland. Peptides 20 (1999), 1479–1487.
53. McCrink, K.A., Brill, A., Lymperopoulos, A., Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure. World J. Cardiol. 7 (2015), 539–543.
54. (2+) entry through store-operated channels to activate tyrosine hydroxylase in bovine chromaffin cells. Eur. J. Neurosci. 15 (2002), 1485–1492.
55. Nagy, G., Reim, K., Matti, U., Brose, N., Binz, T., Rettig, J., Neher, E., Sorensen, J.B., Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25. Neuron 41 (2004), 417–429.
56. Nguyen, K., Kassimatis, T., Lymperopoulos, A., Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells. Cell Commun. Signal., 9, 2011, 5.
57. Nielsen, H.S., Hannibal, J., Fahrenkrug, J., Prenatal expression of pituitary adenylate cyclase activating polypeptide (PACAP) in autonomic and sensory ganglia and spinal cord of rat embryos. Ann. N.Y. Acad. Sci. 865 (1998), 533–536.
58. 2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells. J. Biol. Chem. 278 (2003), 1663–1670.
59. Philipp, M., Hein, L., Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol. Ther. 101 (2004), 65–74.
60. Pons, J., Kitlinska, J., Ji, H., Lee, E.W., Zukowska, Z., Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can. J. Physiol. Pharmacol. 81 (2003), 177–185.
61. Powell, A.D., Teschemacher, A.G., Seward, E.P., P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J. Neurosci. 20 (2000), 606–616.
62. Rengo, G., Leosco, D., Zincarelli, C., Marchese, M., Corbi, G., Liccardo, D., Filippelli, A., Ferrara, N., Lisanti, M.P., Koch, W.J., Lymperopoulos, A., Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am. J. Physiol. Heart Circ. Physiol. 298 (2010), H2032–H2038.
63. Rengo, G., Lymperopoulos, A., Koch, W.J., Future G protein-coupled receptor targets for treatment of heart failure. Curr. Treat. Options Cardiovasc. Med. 11 (2009), 328–338.
64. Rengo, G., Lymperopoulos, A., Leosco, D., Koch, W.J., GRK2 as a novel gene therapy target in heart failure. J. Mol. Cell. Cardiol. 50 (2011), 785–792.
65. Rengo, G., Lymperopoulos, A., Zincarelli, C., Femminella, G., Liccardo, D., Pagano, G., de Lucia, C., Cannavo, A., Gargiulo, P., Ferrara, N., Perrone Filardi, P., Koch, W., Leosco, D., Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2)-adrenoceptor-catecholamine production axis in heart failure. Br. J. Pharmacol. 166 (2012), 2430–2440.
66. Renshaw, D., Thomson, L.M., Michael, G.J., Carroll, M., Kapas, S., Hinson, J.P., Adrenomedullin receptor is found exclusively in noradrenaline-secreting cells of the rat adrenal medulla. J. Neurochem. 74 (2000), 1766–1772.
67. Santulli, G., Campanile, A., Spinelli, L., Assante di Panzillo, E., Ciccarelli, M., Trimarco, B., Iaccarino, G., G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am. J. Cardiol. 107 (2011), 1125–1130.
68. Santulli, G., Trimarco, B., Iaccarino, G., G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press. Cardiovasc. Prev. 20 (2013), 5–12.
69. Schneider, J., Lother, A., Hein, L., Gilsbach, R., Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis. Basic Res. Cardiol. 106 (2011), 591–602.
70. Shimoda, K., Shen, G.H., Pfeiffer, R.F., McComb, R.D., Yang, H.Y., Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells. Neurochem. Int. 23 (1993), 71–77.
71. Shimosawa, T., Fujita, T., Adrenomedullin and its related peptide. Endocr. J. 52 (2005), 1–10.
72. Sorriento, D., Santulli, G., Franco, A., Cipolletta, E., Napolitano, L., Gambardella, J., Gomez-Monterrey, I., Campiglia, P., Trimarco, B., Iaccarino, G., Ciccarelli, M., Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy. J. Cardiovasc. Transl. Res. 8 (2015), 493–502.
73. Spinazzi, R., Andreis, P.G., Nussdorfer, G.G., Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions. Int. J. Mol. Med. 15 (2005), 3–13.
74. Taraviras, S., Olli-Lähdesmäki, T., Lymperopoulos, A., Charitonidou, D., Mavroidis, M., Kallio, J., Scheinin, M., Flordellis, C., Subtype-specific neuronal differentiation of PC12 cells transfected with alpha2-adrenergic receptors. Eur. J. Cell Biol. 81 (2002), 363–374.
75. Thouennon, E., Pierre, A., Yon, L., Anouar, Y., Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma. Cell. Mol. Neurobiol. 30 (2010), 1383–1389.
76. Tseng, C.J., Chan, J.Y., Lo, W.C., Jan, C.R., Modulation of catecholamine release by endogenous adenosine in the rat adrenal medulla. J. Biomed. Sci. 8 (2001), 389–394.
77. (2+) channel types in bovine chromaffin cells. Eur. J. Physiol. 439 (2000), 304–314.
78. Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B.K., Hashimoto, H., Galas, L., Vaudry, H., Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61 (2009), 283–357.
79. Villanueva, M., Wightman, R.M., Facilitation of quantal release induced by a D1-like receptor on bovine chromaffin cells. Biochemistry 46 (2007), 3881–3887.
80. Wallace, D.J., Chen, C., Marley, P.D., Histamine promotes excitability in bovine adrenal chromaffin cells by inhibiting an M-current. J. Physiol. 540 (2002), 921–939.
81. Weber, K.T., Aldosterone in congestive heart failure. N. Engl. J. Med. 345 (2001), 1689–1697.
82. Womble, J.R., Larson, D.F., Copeland, J.G., Brown, B.R., Haddox, M.K., Russell, D.H., Adrenal medulla denervation prevents stress-induced epinephrine plasma elevation and cardiac hypertrophy. Life Sci. 27 (1980), 2417–2420.
83. 2+-dependent binding of synaptotagmin to the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Mol. Pharmacol. 72 (2007), 1210–1219.
84. Yoon, E.J., Hamm, H.E., Currie, K.P., G protein betagamma subunits modulate the number and nature of exocytotic fusion events in adrenal chromaffin cells independent of calcium entry. J. Neurophysiol. 100 (2008), 2929–2939.
85. Zaika, O.L., Pochynyuk, O.M., Kostyuk, P.G., Yavorskaya, E.N., Lukyanetz, E.A., Acetylcholine-induced calcium signalling in adrenaline- and noradrenaline-containing adrenal chromaffin cells. Arch. Biochem. Biophys. 424 (2004), 23–32.
86. Zukowska, Z., Pons, J., Lee, E.W., Li, L., Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?. Can. J. Physiol. Pharmacol. 81 (2003), 89–94.